720 ORAL An intensive weekly chemotherapeutic regimen with 5fluorouracil, leucovorin, cisplatin and epidoxorubicin (PELFw) as adjuvant treatment in high-risk radically resected gastric cancer patients: results of a randomised controlled trial

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Chemotherapeutic Regimen ◽

Gastric Cancer Patients ◽

Randomised Controlled ◽

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djm092 ◽

2007 ◽

Vol 99 (17) ◽

pp. 1345-1346 ◽

Cited By ~ 3

Author(s):

N. Fazio ◽

R. Biffi ◽

G. Curigliano ◽

K. Lorizzo ◽

M. G. Zampino ◽

...

Keyword(s):

Gastric Cancer ◽

Randomized Controlled Trial ◽

High Risk ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Randomized Controlled ◽

Gastric Cancer Patients ◽

Response: Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djm094 ◽

2007 ◽

Vol 99 (17) ◽

pp. 1346-1347

Author(s):

S. Cascinu ◽

M. Scartozzi ◽

C. Barone ◽

R. Labianca ◽

A. Santoro ◽

...

Keyword(s):

Gastric Cancer ◽

Randomized Controlled Trial ◽

High Risk ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Randomized Controlled ◽

Gastric Cancer Patients ◽

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djk131 ◽

2007 ◽

Vol 99 (8) ◽

pp. 601-607 ◽

Cited By ~ 71

Author(s):

S. Cascinu ◽

R. Labianca ◽

C. Barone ◽

A. Santoro ◽

C. Carnaghi ◽

...

Keyword(s):

Gastric Cancer ◽

Randomized Controlled Trial ◽

High Risk ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Randomized Controlled ◽

Gastric Cancer Patients ◽

Acupressure improves the postoperative comfort of gastric cancer patients: A randomised controlled trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2015.03.010 ◽

2015 ◽

Vol 23 (3) ◽

pp. 339-346 ◽

Cited By ~ 14

Author(s):

Wan-Ting Hsiung ◽

Yi-Chuan Chang ◽

Mei-Ling Yeh ◽

Yung-Hsien Chang

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Gastric Cancer Patients ◽

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou’s Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

European Urology ◽

10.1016/j.eururo.2016.06.043 ◽

2017 ◽

Vol 71 (1) ◽

pp. e31-e32

Author(s):

Tom J.H. Arends ◽

J. Alfred Witjes

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6602468 ◽

2005 ◽

Vol 92 (6) ◽

pp. 1051-1054 ◽

Cited By ~ 11

Author(s):

M Scartozzi ◽

E Galizia ◽

F Graziano ◽

V Catalano ◽

R Berardi ◽

...

Keyword(s):

Gastric Cancer ◽

High Risk ◽

Cancer Patients ◽

Gastric Cancer Patients ◽

Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

European Urology ◽

10.1016/j.eururo.2018.08.045 ◽

2019 ◽

Vol 75 (2) ◽

pp. e26

Author(s):

Tom J.H. Arends ◽

J. Alfred Witjes

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046–52

European Urology ◽

10.1016/j.eururo.2016.06.042 ◽

2017 ◽

Vol 71 (1) ◽

pp. e29-e30

Author(s):

Sławomir Poletajew ◽

Piotr Radziszewski ◽

Juan Palou

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer

European Urology ◽

10.1016/j.eururo.2016.01.006 ◽

2016 ◽

Vol 69 (6) ◽

pp. 1046-1052 ◽

Cited By ~ 91

Author(s):

Tom J.H. Arends ◽

Ofer Nativ ◽

Massimo Maffezzini ◽

Ottavio de Cobelli ◽

Giorgio Canepa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽